Akers Biosciences Inc - 48 Year Dividend History | AKER

Historical dividend payout and yield for Akers Biosciences Inc (AKER) since 1971. The current TTM dividend payout for Akers Biosciences Inc (AKER) as of April 18, 2019 is $0.00. The current dividend yield for Akers Biosciences Inc as of April 18, 2019 is 0.00%.
Sector Industry Market Cap Revenue
Medical Medical Products Manufacturing $0.010B $0.002B
Akers Biosciences, Inc. develops, manufactures and supplies rapid, point-of-care screening and testing products. The Company's products primarily includes BreathScan(R), BreathScan PRO(R), METRON(R), VIVO(TM), Heparin/PF4 Antibody Serum Panels(R) and Breath Ketone. Akers Biosciences, Inc. is based in Thorofare, United States.
Stock Name Country Market Cap PE Ratio
Abbott Laboratories (ABT) United States $129.838B 25.32
Medtronic (MDT) Ireland $112.952B 16.51
Stryker (SYK) United States $67.256B 24.66
Baxter (BAX) United States $37.991B 24.37
Zimmer Biomet Holdings (ZBH) United States $24.550B 15.71
Smith & Nephew SNATS (SNN) United Kingdom $16.615B 0.00
ResMed (RMD) United States $14.218B 26.96
Perrigo (PRGO) Ireland $6.633B 10.75
Hill-Rom Holdings (HRC) United States $6.374B 19.72
Phibro Animal Health (PAHC) United States $1.349B 19.38
LeMaitre Vascular (LMAT) United States $0.536B 25.46
Meridian Bioscience (VIVO) United States $0.531B 15.82
Utah Medical Products (UTMD) United States $0.321B 20.88
Owens & Minor (OMI) United States $0.213B 2.91
United-Guardian (UG) United States $0.088B 20.06